Harbor Capital Advisors, Inc. Cytokinetics Inc Transaction History
Harbor Capital Advisors, Inc.
- $2.3 Billion
- Q3 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 42,526 shares of CYTK stock, worth $2.09 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
42,526
Previous 17,814
138.72%
Holding current value
$2.09 Million
Previous $965,000
132.64%
% of portfolio
0.1%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding CYTK
# of Institutions
410Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$720 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$577 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$476 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$382 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$317 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.62B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...